AzTrials
AzTrials

Alzheimer DiseaseM4MNCT06611878

Memory for Music: Individual Intensive Musical Training in Alzheimer's Disease

A study testing Music training - intensive, Music training - minimal and Treatment as Usual (TAU) in people with Alzheimer Disease, run by NORCE Norwegian Research Centre AS at 6 sites in 3 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This project, called Memory for Music, focuses on the increasing number of people worldwide living with dementia, especially Alzheimer's disease (AD). AD typically starts with memory problems and eventually affects daily activities. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Alzheimer Disease
What is being tested?
Music training - intensive, Music training - minimal and Treatment as Usual (TAU)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
113 participants
Where
6 sitesin 3 countries
Study dates
1 Dec 2024to 1 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Diagnosis of Alzheimer's disease
  • Home-dwelling
  • Non-musician

Who cannot join

  • Non-Alzheimer dementia
  • Living in care home
  • History as a professional musician

Trial locations and contacts

6 sites in 3 countries. Contact the study team or a site near you to ask about taking part.

6 sites in 3 countries

Norway4 sites, 4 recruiting
  • University of Bergen

    Bergen, Vestland, 5020

    Elias Langeland, 004790628887, elil@norceresearch.no

    Recruiting
  • Haraldsplass Diakonale Sykehus

    Bergen, Vestland, 5892

    Ragnhild Skogseth, ragnhild.eide.skogseth@haraldsplass.no

    Recruiting
  • Kinn municipality

    Florø

    Jorunn B Nydal, jorunn.nydal@kinn.kommune.no

    Recruiting
  • Oslo municipality

    Oslo

    Elin Linløkken, elin.linlokken@bna.oslo.kommune.no

    Recruiting

Other trials in Norway

Argentina1 site, 1 recruiting
  • Universidad de Ciencias Empresariales y Sociales

    Buenos Aires

    Marcela Lichtensztejn, marcela.lichtensztejn@gmail.com

    Recruiting

Other trials in Argentina

Austria1 site, 1 recruiting
  • University of Vienna

    Vienna

    Anja-Xiaoxing Cui, anja-xiaoxing.cui@univie.ac.at

    Recruiting

Other trials in Austria

About this study

Official title: Memory for Music: Effects of Individual Intensive Musical Training Based on Singing in Non-musicians With Alzheimer's Disease

This project, called Memory for Music, focuses on the increasing number of people worldwide living with dementia, especially Alzheimer's disease (AD). AD typically starts with memory problems and eventually affects daily activities. Active music interventions, especially singing, have shown positive effects on mood, behavior, and quality of life for people with dementia, but their impact on cognition is not well understood. The project aims to address this gap by studying the effects of learning new songs on cognitive, behavioral, and brain functioning.

The study will involve home-dwelling adults aged 65 or older with AD from Argentina, Austria, and Norway. Participants will undergo 5 months of intensive musical training (twice a week) and 5 months of minimal training (once a month) in a random order, with a 2-month break in between. The interventions include learning new songs with a personal music teacher. General cognition will be measured using the Alzheimer's Disease Assessment Scale - Cognitive (ADAS-cog), and memory for music will be assessed through various methods, including behavioral tasks and brain responses (EEG). Mood will also be evaluated in each session.

The goal is to include 113 participants to ensure reliable detection of meaningful effects. The study will explore how mood and memory for music contribute to changes in cognitive abilities, and whether these effects vary based on factors such as sex, age, AD stage, or previous musical training and general education. The project emphasizes collaboration between researchers, service providers, and users to ensure the study's relevance and applicability.

Read the detailed description

The number of people living with dementia is increasing and is high in low, middle, and high-income countries. Alzheimer's disease (AD), the most common type of dementia, manifests itself initially with cognitive impairment in memory domains, and later affects all activities of daily living. Active music interventions, particularly singing, can help to improve mood, behaviour problems, and quality of life. Too little is known about their effects on cognition, although some promising studies exist. The M4M project aims to fill this gap by measuring effects of learning new songs on clinical, behavioural and brain functioning. Specifically, M4M aims to examine changes in general cognitive functioning and memory for music in non-musician adults with AD undergoing intensive individual musical training based on singing novel songs, compared to minimal training.

Home-dwelling adults with AD, 65 years or older, in 3 countries (Argentina, Austria, Norway), will receive 5 months of intensive intervention (2x/week) and 5 months of minimal intervention (1x/month), in random order, with a 2-month break in between. Interventions will entail learning new songs with an individual music teacher. At the end of each intervention period, general cognition will be measured with the Alzheimer's Disease Assessment Scale - Cognitive (ADAS-cog) by a person who is unaware of the intervention received. Memory for music will be tested with observations, behavioural tasks, and brain responses (EEG). Mood will be assessed in each session. The investigators aim to include 113 participants; this will help us to reliably detect clinically meaningful effects. The investigators will also examine how mood and memory for music lead to changes in cognitive abilities, and whether effects depend on sex, age, AD stage, or previous musical training or general education. M4M will be conducted in close collaboration between academic researchers, service providers, and service users to ensure relevance and applicability.

Behavioural assessment will be conducted by the instructors and by external evaluators at specific points of the musical training. Mood will be assessed using a 5-point emoji scale, and Sense of Familiarity with the current song will be estimated using a scale that takes into account verbal and behavioural cues; both measures were developed for the purpose of this study.

EEG measures will be collected while participants listen to both unknown melodies and melodies they have learned during the intervention period, and the investigators wish to assess whether in-key violations in known songs will elicit an N400-like event related potential. If participants develop musical semantic memory through our intervention, the investigators expect them to show this N400-like component to in-key violations in familiarized melodies, i.e., those melodies that are introduced and learned during our intervention, but only after the intervention. If an N400 component is detectable during these in-key violations of a newly learned song, it will indicate memory of the new song even if the participant is unable to adhere to a behavioural task or display an observable sense of familiarity. The in-key violations will be introduced at multiple places throughout each melody, which will consist of at least 32 bars. A total of 10 melodies will be played for each participant, of which half are learned in an intervention period (familiarized/to be familiarized). In each of the melodies the investigators will include at least 8 in-key violations. ERPs in response to these in-key violations will be compared to ERPs in response to unchanged notes in structurally similar places in each melody.

Being tested
Music training - intensive, Music training - minimal, Treatment as Usual (TAU)
Keywords
music and memory, N400, music-based intervention, music therapy, dementia, cognition, mood
Medical subject headings
Alzheimer Disease, Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Music training - intensiveBehavioural

    Music training entails learning novel songs the participant chooses from a list. Songs are similar in complexity and length (number of words, high frequency words, harmony, musical complexity, length of verses and chorus). Offering a variety of songs allows to examine memory performance regardless of the specific song chosen. Sessions last 30 to 40 minutes, conducted based on a manual (1. mood observation; 2. warm-up; 3. teaching the chorus, observed liking of song; 4. singing entire chorus; 5. singing chorus in context, 6. session closure with favourite song; 7. final mood observation; session rating), and are video-recorded. External evaluators audit the sessions video recordings to determine adherence to the manual. Sessions are offered twice a week for 5 months.

  • Music training - minimalBehavioural

    Music training entails learning novel songs the participant chooses from a list. Songs are similar in complexity and length (number of words, high frequency words, harmony, musical complexity, length of verses and chorus). Offering a variety of songs allows to examine memory performance regardless of the specific song chosen. Sessions last 30 to 40 minutes, conducted based on a manual (1. mood observation; 2. warm-up; 3. teaching the chorus, observed liking of song; 4. singing entire chorus; 5. singing chorus in context, 6. session closure with favourite song; 7. final mood observation; session rating), and are video-recorded. External evaluators audit the sessions video recordings to determine adherence to the manual. Sessions are offered once a month for 5 months.

  • Treatment as Usual (TAU)Other

    Medications, behavioural interventions and other treatments that participants may receive outside the study during the period of participation.

Study groups in NCT06611878
Study groupRoleWhat they receive
Intensive followed by minimal music trainingExperimentalMusic training conducted by a trained instructor (music therapist or music educator): 2 sessions per week for 5 months (intensive); no intervention for 2 months (washout period); 1 session per month for 5 months (minimal).
Receives: Behavioral: Music training - intensive; Behavioral: Music training - minimal; Other: Treatment as Usual (TAU)
Minimal followed by intensive music trainingExperimentalMusic training conducted by a trained instructor (music therapist or music educator): 1. session per month for 5 months (minimal); no intervention for 2 months (washout period); 2. sessions per week for 5 months (intensive).
Receives: Behavioral: Music training - intensive; Behavioral: Music training - minimal; Other: Treatment as Usual (TAU)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ADAS-cog

    ADAS-cog is a scale developed to assess the level of cognitive dysfunction in individuals with Alzheimer's disease.

    The standard ADAS-cog includes the following 11 subtests, with a total scoring range from 0 (no impairment) to 70 (most severe impairments): word recall (0-10); commands (0-5); naming (0-5); constructional praxis (0-5); ideational praxis (0-5); orientation (0-8); word recognition (0-12); remembering word recognition test instructions (0-5); spoken language ability (0-5); comprehension of spoken language (0-5); word-finding difficulty (0-5). The ADAS-cog score is based on the number of errors made within each subtest.

    Measured: 0, 5, 7, 12 months

  2. EEG-ERP N400 in response to music stimuli

    Electroencephalography (EEG) is a non-invasive method of measuring brain activity. Electrical potential from the brain is measured through electrodes on a cap fitted on the head of the participant. Event-related potentials (ERPs) in response to music violations (unexpected notes in songs) will be analysed to indicate implicit memory for learned music. Generally, ERPs are measured by averaging the EEG signal over multiple repetitions of the same stimulus response. In this study, ERP analyses will focus on amplitude variation of the N400 component, which is a negative inflection of the EEG signal around 400ms after the onset of a stimulus (here an unexpected note in a song presented via audio recording). It is measured in µV and results in a continuous variable. Because the direction of the N400 is negative, and a stronger response indicates better music memory, lower amplitudes values are interpreted as more favourable outcomes.

    Measured: 0, 5, 7, 12 months

Secondary outcomes (8)
  1. Mood

    Self-reported mood at beginning and end of each training session, using a 5-point scale with emojis (icons of faces where 1=sad and 5=happy; higher values mean better outcome).

    Measured: Beginning and end of each training session, i.e. min. 1x/month, max. 10x/month, during months 1-5 and 7-12.

  2. Sense of Familiarity with current song (Instructor)

    Rated by intervention provider during the training session. Ratings for estimated Sense of Familiarity: 1 - None; 2 - Implicit memory, mere exposure effect; 3 - Weak familiarity; 4 - Familiarity; 5 - Weak recollection; 6 - Recollection. For this study, a score of 4 or above is considered as the threshold to determine familiarity-based recognition.

    Measured: During each training session, i.e. min. 1x/month, max. 10x/month, during months 1-5 and 7-12.

  3. Sense of Familiarity with current song (External Evaluator)

    Rated by an external evaluator based on video recordings of training sessions. Ratings for estimated Sense of Familiarity: 1 - None; 2 - Implicit memory, mere exposure effect; 3 - Weak familiarity; 4 - Familiarity; 5 - Weak recollection; 6 - Recollection. For this study, a score of 4 or above is considered as the threshold to determine familiarity-based recognition.

    Measured: At the end of selected training sessions (last session of each month and when the instructor's rating changes), during months 1-5 and 7-12.

  4. Performance (chorus solo)

    Performance (independent recall) of a learned song during solo performance, whether the participant needs full support / intermittent support / support in one syllable/word per line / is fully independent. Rated by an external evaluator based on video recordings of training sessions. Possible range 8-32, where highest is best.

    Measured: During selected training sessions (last session of each month and when the instructor's rating changes), during months 1-5 and 7-12.

  5. Performance (chorus in context)

    Performance (independent recall) of a learned song during performance in context, whether the participant needs full support / intermittent support / support in one syllable/word per line / is fully independent. Rated by an external evaluator based on video recordings of training sessions. Possible range 2-8, where highest is best.

    Measured: During selected training sessions (last session of each month and when the instructor's rating changes), during months 1-5 and 7-12.

  6. Adverse events

    The investigators will ask participants or relatives at each assessment time point about the occurrence and a description of any serious or non-serious adverse events (AEs). Potentially study-related serious AEs, as well as unblinded frequency counts of any AEs, will be shared and discussed with the Data Monitoring and Safety Committee (DSMC) through the trial statistician.

    Measured: 5, 7, 12 months

  7. Structural brain characteristics

    Assessed using quantitative and diffusion-weighted magnetic resonance imaging (MRI; 3 Tesla).

    This outcome measure will only be included at the Vienna site.

    Measured: 0, 5 months

  8. Functional brain connectivity metrics

    Assessed during task-free resting state functional magnetic resonance imaging (fMRI: 3 Tesla).

    This outcome measure will only be included at the Vienna site.

    Measured: 0, 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2024
  2. Study start1 Dec 2024
  3. Primary completion1 Oct 2027 (estimated)
  4. Study completion1 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Randomised crossover design
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
113 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06611878
Sponsor's protocol ID
106684
Other IDs
344215
Acronym
M4M
Status last verified
Jan 2026
First submitted
5 Sep 2024
Last updated
8 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Scripting and statistical analysis of baseline and outcome data will be followed by reporting of outcomes in publications and sharing of de-identified individual participant data and analysis code in a public repository.

Publications

  • Lichtensztejn M, Cui AX, Geretsegger M, Lundervold AJ, Koelsch S, Pfabigan DM, Assmus J, Langeland E, Ruiz M, Tabernig C, Skogseth RE, Gold C. Memory for Music (M4M) protocol for an international randomised controlled trial: effects of individual intensive musical training based on singing in non-musicians with Alzheimer's disease. BMJ Open. 2025 Oct 20;15(10):e095136. doi: 10.1136/bmjopen-2024-095136.

    PubMed 41120149

Questions about this trial

What is this clinical trial studying?

A study testing Music training - intensive, Music training - minimal and Treatment as Usual (TAU) in people with Alzheimer Disease, run by NORCE Norwegian Research Centre AS at 6 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Norway, Argentina, Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elias Langeland (0047 90628887, elil@norceresearch.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ADAS-cog (time frame: 0, 5, 7, 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06611878, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in